Perspective: The clinical trial barriers

Nature

Volumn 480, Issue 7378, 2011, Pages S100-

  Liu, Liang ^a   Leung, Elaine Lai Han ^a   Tian, Xiaoying ^b  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ASIA; GOLD STANDARD; HUMAN; NOTE; PERSONALIZED MEDICINE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRADITIONAL MEDICINE;

EID: 84055184878     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/480S100a     Document Type: Article

References (7)

1. Swanton, C. & Caldas, C. Ann. N. Y Acad. Sci. 1210, 34-44 (2010).
2. Frueh, F W. Pharmacogenomics 10, 1077-1081 (2009).
3. Douillard, J. Y. et al. J. Clin. Oncol. 28, 744-752 (2010).
4. Lynch, T. J. et al. N. Engl. J. Med. 350, 2129-2139 (2004).
5. Paez, J. G. et al. Science 304, 1497-1500 (2004).
6. van der Greef, J. et al. Planta Med. 76, 2036-2047 (2010).
7. van Wietmarschen, H. et al. J. Clin. Rheumatol. 15, 330-337 (2009).